Proteomics International Laboratories Ltd (ASX:PIQ) Investor Presentation
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of its latest investor presentation for a non-deal roadshow to institutional investors.
Companies in the News
Biotech
Proteomics International Laboratories Ltd (ASX:PIQ) September 2023 Quarterly Activities Report
Proteomics International Laboratories Ltd (ASX:PIQ), a medical technology company at the forefront of precision medicine and predictive diagnostics, is pleased to provide the following update on its business activities for the three months to 30 September 2023 and subsequent to the period end.
Apiam Animal Health Limited (ASX:AHX) Q1 FY24 Performance Update
Apiam Animal Health Limited (ASX:AHX) today announced an update on the Company's performance for the quarter ended 30 September 2023 (Q1 FY24).
Anatara Lifesciences Limited (ASX:ANR) Webinar on the Company's Stage 1 Irritable Bowel Syndrome
Anatara Lifesciences (ASX:ANR) is pleased to invite shareholders, investors and interested parties to an online Webinar on the Company's Stage 1 Irritable Bowel Syndrome (IBS) clinical trial results, hosted by Chair, Dr. David Brookes.
Proteomics International Laboratories Ltd (ASX:PIQ) International Webinar and Q&A
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the PromarkerD US Reimbursement Price.
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD US Reimbursement Price & Aus Regulatory Decision
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.
Ellis Martin Report with TONIX Pharmaceuticals Holding Corp.'s (NASDAQ:TNXP) Dr Seth Lederman
Join Ellis Martin for a compelling interview with Dr. Seth Lederman. He's an MD and the CEO of TONIX Pharmaceuticals Holding Corp. (NASDAQ:TNXP).
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Social Media
